Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro.

We have previously identified a gene, beta ig-h3, which is highly induced in A549 cells (human lung adenocarcinoma) after growth arrest by transforming growth factor-beta. The beta ig-h3 gene encodes a 683-amino-acid secretory protein termed beta IG-H3, and treatment of several cell lines with transforming growth factor-beta results in increased secretion of beta IG-H3 into cell culture supernatants. In this report, we further characterize beta IG-H3 with respect to its synthesis and function. Primary human foreskin fibroblasts grown in monolayer culture produced beta IG-H3 mRNA and secreted beta IG-H3 protein into the growth media. Treatment of these cells with transforming growth factor-beta led to an increase in beta IG-H3 mRNA and protein. Cells grown on three-dimensional scaffolds secreted beta IG-H3 into the extracellular matrix, as judged by immunostaining with anti-beta IG-H3 antibodies. beta IG-H3 was also detected in normal human skin, especially in the papillary dermis. Finally, we show that recombinant beta IG-H3 supported attachment and spreading of dermal fibroblasts, suggesting that beta IG-H3 may function as an extracellular attachment protein in skin.

[1]  J. Crabb,et al.  cDNA from human ocular ciliary epithelium homologous to βig‐h3 is preferentially expressed as an extracellular protein in the corneal epithelium , 1994, Journal of cellular physiology.

[2]  M. P. Welch,et al.  TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. , 1994, The Journal of investigative dermatology.

[3]  Hans Marquardt,et al.  βig-h3: A Transforming Growth Factor-β-Responsive Gene Encoding a Secreted Protein That Inhibits Cell Attachment In Vitro and Suppresses the Growth of CHO Cells in Nude Mice , 1994 .

[4]  K. Miyazono,et al.  Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.

[5]  J. Massagué,et al.  Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.

[6]  K. Miyazono,et al.  Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.

[7]  Characterization of a human dermal replacement , 1993 .

[8]  M. Bissell,et al.  Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  R. Derynck,et al.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. , 1993, Science.

[10]  L. Madisen,et al.  cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β , 1992 .

[11]  D. Sheppard,et al.  Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. , 1992, The Journal of biological chemistry.

[12]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[13]  R. Weinberg,et al.  Expression cloning and characterization of the TGF-β type III receptor , 1991, Cell.

[14]  P. Hanawalt,et al.  Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing , 1991, Journal of cellular physiology.

[15]  J. Elias,et al.  Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts. , 1991, Journal of immunology.

[16]  M L Cooper,et al.  In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. , 1991, Biomaterials.

[17]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[18]  R. Ross,et al.  TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. , 1990, Cell.

[19]  H. Moses,et al.  The cell biology of transforming growth factor β , 1990 .

[20]  R. Stein,et al.  Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[22]  E. Ruoslahti,et al.  Multiple domains of the large fibroblast proteoglycan, versican. , 1989, The EMBO journal.

[23]  K. Alitalo,et al.  Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation , 1989, Molecular and cellular biology.

[24]  J. Massagué,et al.  Regulation of cell adhesion receptors by transforming growth factor-beta. Regulation of vitronectin receptor and LFA-1. , 1989, The Journal of biological chemistry.

[25]  L. Madisen,et al.  Transforming growth factor-beta 2: cDNA cloning and sequence analysis. , 2009, DNA.

[26]  M. Rosner,et al.  Transforming growth factor-beta increases transcription of the genes encoding the epidermal growth factor receptor and fibronectin in normal rat kidney fibroblasts. , 1988, The Journal of biological chemistry.

[27]  J. Massagué,et al.  The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. , 1988, The Journal of biological chemistry.

[28]  H. Marquardt,et al.  Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide , 1988, Molecular and cellular biology.

[29]  P. Segarini,et al.  The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains. , 1988, The Journal of biological chemistry.

[30]  C. Goodman,et al.  Sequence analysis and neuronal expression of fasciclin I in grasshopper and drosophila , 1988, Cell.

[31]  E Ruoslahti,et al.  New perspectives in cell adhesion: RGD and integrins. , 1987, Science.

[32]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[33]  H. Moses,et al.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Bevan,et al.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  U. Landegren.  Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. , 1984, Journal of immunological methods.

[36]  A. Ben-Ze'ev,et al.  The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts , 1978, Cell.

[37]  J. Folkman,et al.  Role of cell shape in growth control , 1978, Nature.

[38]  H. Boedtker,et al.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. , 1977, Biochemistry.

[39]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.